Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Krazati
Pharma
BMS touts KRAS confirmatory trial win after Amgen's stumble
Krazati's confirmatory trial win in second-line NSCLC comes as Amgen had to run another phase 3 study to support Lumakras' accelerated approval.
Angus Liu
Mar 29, 2024 10:35am
EU regulators back Mirati's Krazati after initial rebuff
Nov 10, 2023 11:15am
Securities filing details BMS' yearslong courtship of Mirati
Oct 24, 2023 11:41am
BMS buys Mirati for up to $5.8B as I-O giant branches out
Oct 9, 2023 3:29am
Amgen flunks Lumakras AdComm, but market pull looks unlikely
Oct 5, 2023 4:45pm
Sanofi weighs acquisition of Mirati: Bloomberg
Oct 5, 2023 3:48pm